These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38262847)

  • 1. Association of metabolic syndrome components and NAFLD with quality of life: Insights from a cross-sectional study.
    Borges-Canha M; Leite AR; Godinho T; Liberal R; Correia-Chaves J; Lourenço IM; von Hafe M; Vale C; Fragão-Marques M; Pimentel-Nunes P; Leite-Moreira A; Carvalho D; Freitas P; Neves JS
    Prim Care Diabetes; 2024 Apr; 18(2):196-201. PubMed ID: 38262847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
    Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
    Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography.
    Lavor CBH; Viana Júnior AB; Medeiros FDC
    Rev Bras Ginecol Obstet; 2022 Mar; 44(3):287-294. PubMed ID: 35576937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
    Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort.
    Martínez-Urbistondo D; San Cristóbal R; Villares P; Martínez-González MÁ; Babio N; Corella D; Del Val JL; Ordovás JM; Alonso-Gómez ÁM; Wärnberg J; Vioque J; Romaguera D; López-Miranda J; Estruch R; Tinahones FJ; Lapetra J; Serra-Majem JL; Bueno-Cavanillas A; Tur JA; Marcos A; Pintó X; Delgado-Rodríguez M; Matía-Martín P; Vidal J; Vázquez C; Ros E; Bullón Vela MV; Palau A; Masagué M; Abete I; Moreno-Rodríguez A; Candela-García I; Konieczna J; García-Ríos A; Juárez OL; Martín P; Goday A; Zulet MÁ; Vaquero-Luna J; Orea MDCS; Megías I; Baltasar E; Martínez JA; Daimiel L
    Front Endocrinol (Lausanne); 2022; 13():868795. PubMed ID: 35846291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tissue inhibitor of metalloproteinase 2 with non-alcoholic fatty liver disease in metabolic syndrome.
    Yasmeen S; Khan U; Khan GM; Fatima SS
    Arch Physiol Biochem; 2019 Dec; 125(5):441-446. PubMed ID: 29912573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome.
    Kuo TC; Lu YB; Yang CL; Wang B; Chen LX; Su CP
    BMC Gastroenterol; 2024 Jan; 24(1):26. PubMed ID: 38195414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease.
    Georgoulis M; Kontogianni MD; Margariti A; Tiniakos D; Fragopoulou E; Zafiropoulou R; Papatheodoridis G
    J Hum Nutr Diet; 2015 Aug; 28(4):409-15. PubMed ID: 25988570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement.
    Huang Z; Ng K; Chen H; Deng W; Li Y
    Front Endocrinol (Lausanne); 2021; 12():739875. PubMed ID: 35173677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
    J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.